Bioton S.A. - Asset Resilience Ratio

Latest as of December 2017: 0.01%

Bioton S.A. (BIO) has an Asset Resilience Ratio of 0.01% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Bioton S.A. to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

zł163.00K

≈ $44.86K USD Cash + Short-term Investments

Total Assets

zł1.14 Billion

≈ $314.29 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2019)

This chart shows how Bioton S.A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BIO total asset value.

Liquid Assets Composition Over Time

This chart breaks down Bioton S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Bioton S.A. long-term investment allocation to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	zł0.00	0%
Short-term Investments	zł163.00K	0.01%
Total Liquid Assets	zł163.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Bioton S.A. maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bioton S.A. Industry Peers by Asset Resilience Ratio

Compare Bioton S.A.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Bioton S.A. (2005–2019)

The table below shows the annual Asset Resilience Ratio data for Bioton S.A..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.20%	zł1.72 Million ≈ $474.19K	zł881.42 Million ≈ $242.58 Million	-2.28pp
2016-12-31	2.47%	zł32.02 Million ≈ $8.81 Million	zł1.30 Billion ≈ $356.45 Million	+1.92pp
2015-12-31	0.56%	zł6.95 Million ≈ $1.91 Million	zł1.25 Billion ≈ $344.03 Million	+0.53pp
2013-12-31	0.03%	zł491.00K ≈ $135.13K	zł1.89 Billion ≈ $520.37 Million	-0.71pp
2011-12-31	0.73%	zł14.83 Million ≈ $4.08 Million	zł2.02 Billion ≈ $557.19 Million	-0.87pp
2010-12-31	1.61%	zł25.42 Million ≈ $7.00 Million	zł1.58 Billion ≈ $435.30 Million	+0.72pp
2009-12-31	0.89%	zł14.32 Million ≈ $3.94 Million	zł1.60 Billion ≈ $441.67 Million	-1.35pp
2008-12-31	2.24%	zł46.35 Million ≈ $12.76 Million	zł2.06 Billion ≈ $568.26 Million	+0.87pp
2007-12-31	1.37%	zł21.23 Million ≈ $5.84 Million	zł1.55 Billion ≈ $425.52 Million	-5.08pp
2006-12-31	6.46%	zł64.01 Million ≈ $17.62 Million	zł991.63 Million ≈ $272.91 Million	+6.00pp
2005-12-31	0.46%	zł1.65 Million ≈ $452.73K	zł358.12 Million ≈ $98.56 Million	--

pp = percentage points

About Bioton S.A.

WAR:BIO Poland Biotechnology

Market Cap

$87.43 Million

zł317.70 Million PLN

Market Cap Rank

#19768 Global

#159 in Poland

Share Price

zł3.70

Change (1 day)

-0.27%

52-Week Range

zł3.70 - zł4.55

All Time High

zł15.39